| 引用本文: |
孙文婷,汤少梁,段金廒,等.基于共词分析的我国中药材产业政策演进路径探析*[J].中国卫生经济,2023,42(1):9-13,18.[点击复制] |
SUN Wen-ting,TANG Shao-liang,DUAN Jin-ao,et al.Research on the Evolution Path of Chinese Medicinal Materials Industrial Policy Based on Co-world Analysis[J].CHINESE HEALTH ECONOMICS,2023,42(1):9-13,18.[点击复制] |
|
| |
|
|
| 本文已被：浏览 1442次 下载 1744次 |
码上扫一扫！ |
| 基于共词分析的我国中药材产业政策演进路径探析* |
| 孙文婷,汤少梁,段金廒,杨莉 |
|
|
| (南京中医药大学卫生经济管理学院 南京 210023;南京中医药大学,江苏省中药资源产业化过程协同创新中心) |
|
| 摘要: |
| 目的：分析中药材产业政策变迁路径并总结演进逻辑，为国家制定相关政策及产业可持续发展提供参考。方法：系统梳理1978—2022年间国家层面中药材产业相关政策文件，基于ROSTCM及Netdraw软件，挖掘政策文本高频词并构建各阶段政策共词网络，进而对政策文本展开分析。结果：我国中药材产业政策整体践行了“恢复探索→建制化发展→深化改革→创新优化”的演进路径，政策规划与国家战略融合日益紧密，政策主体多元化模式逐渐稳定，政策手段灵活性增强， 且政策内容始终与产业结构演进一致。结论：基于政策演进的接续性，未来可将优质药材建设作为切入点，深化产业与国家战略协同，完善法规标准体系建设，进一步推进中药材产业高速发展。 |
| 关键词: 中药材 产业政策 政策变迁 共词分析 |
| DOI： |
|
| 基金项目:国家中医药多学科交叉创新团队(道地药材生态化与资源可持续利用)支持计划(2021)；江苏省中药资源产业化过程协同创新中心重点项目(ZDXM-2022-09) |
|
| Research on the Evolution Path of Chinese Medicinal Materials Industrial Policy Based on Co-world Analysis |
| SUN Wen-ting,TANG Shao-liang,DUAN Jin-ao,YANG Li |
| () |
| Abstract: |
| Objective: To analyze the evolution path of Chinese medicinal materials industrial policy and summarize the evolution logic，so as to provide references for national policy making and sustainable development of the industry. Methods: The relevant policy documents of the Chinese medicinal materials industry at the national level from 1978 to 2022 were systematically sorted out. Based on ROST CM and Netdraw System Software，the high-frequency words of the policy text were extracted and the policy co-word network of each stage was constructed to analyze the policy text. Results: Industrial policies of Chinese medicinal materials have been put into practice the evolution path of "recovery and exploration，institutionalized development，deepening reform-innovation and optimization". Policy planning and national strategy were increasingly integrated，the diversification mode of policy subjects was gradually stable，the flexibility of policy means was enhanced，and the policy contents were always consistent with the evolution of the industrial structure. Conclusion: Based on the continuous policy evolution，the construction of high-quality medicinal materials can be taken as the breakthrough point in the future，so as to deepen the coordination between industry and national strategy，improve the system of regulations and standards，and further promote the rapid development of Chinese medicinal materials industry. |
| Key words: Chinese medicinal materials policy change industrial development co-word analysis |
|
|